(Q72230770)
Statements
Adjuvant chemoimmunotherapy for hepatocellular carcinoma patients. Adriamycin, interleukin-2, and lymphokine-activated killer cells versus adriamycin alone (English)
A Kawata
Y Une
M Hosokawa
Y Wakizaka
T Namieno
J Uchino